Literature DB >> 12176487

First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV.

J M Langrehr1, U P Neumann, M Lang, A R Müller, S Jonas, U Settmacher, T Steinmüller, P Neuhaus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12176487     DOI： 10.1016/s0041-1345(02)03024-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  10 in total

Review 1.  Corticosteroid-free immunosuppression in liver transplantation: an evidence-based review.

Authors:  George Sgourakis; Georgia Dedemadi
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 2.  Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop.

Authors:  Kymberly D S Watt; Kelly Burak; Marc Deschênes; Les Lilly; Denis Marleau; Paul Marotta; Andrew Mason; Kevork M Peltekian; Eberhard L Renner; Eric M Yoshida
Journal:  Can J Gastroenterol       Date:  2006-11       Impact factor: 3.522

3.  Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a Trial.

Authors:  Khurram Bari; Shimul A Shah; Tiffany E Kaiser; Robert M Cohen; Nadeem Anwar; David Kleesattel; Kenneth E Sherman
Journal:  Liver Transpl       Date:  2020-08-19       Impact factor: 5.799

Review 4.  Corticosteroid-free strategies in liver transplantation.

Authors:  John G O'Grady
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7 years.

Authors:  Shawn J Pelletier; Satish N Nadig; David D Lee; John B Ammori; Michael J Englesbe; Randall S Sung; John C Magee; Robert J Fontana; Jeffrey D Punch
Journal:  HPB (Oxford)       Date:  2012-09-28       Impact factor: 3.647

Review 6.  Management of hepatitis C infection after liver transplantation.

Authors:  Mazen Alsatie; Naga Chalasani; Paul Y Kwo
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 7.  Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.

Authors:  Manuel Rodríguez-Perálvarez; Marta Guerrero-Misas; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-31

Review 8.  Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trials.

Authors:  Jinyang Gu; Xingyu Wu; Lei Lu; Shu Zhang; Jianling Bai; Jun Wang; Jun Li; Yitao Ding
Journal:  Hepatol Int       Date:  2014-03-20       Impact factor: 6.047

9.  Safety and effectiveness of mycophenolate mofetil associated with tacrolimus for liver transplantation immunosuppression: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Francisco Tustumi; Antonio Afonso de Miranda Neto; Sérgio Silveira Júnior; Felipe Alexandre Fernandes; Miller Barreto de Brito E Silva; Lucas Ernani; Lucas Souto Nacif; Fabricio Ferreira Coelho; Wellington Andraus; Wanderley Marques Bernardo; Paulo Herman; Luiz Augusto Carneiro-D'Albuquerque
Journal:  Clinics (Sao Paulo)       Date:  2021-03-08       Impact factor: 2.365

Review 10.  Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.

Authors:  Cameron Fairfield; Luit Penninga; James Powell; Ewen M Harrison; Stephen J Wigmore
Journal:  Cochrane Database Syst Rev       Date:  2018-04-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.